SINO BIOPHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 1177 for the last semiannual is 11.80 B HKD, and it's 31.70% lower compared to the previous semiannual. The net income of H2 23 is 1.16 B HKD.